WANT THE FACTS 
ABOUT ORGOVYX?

You're starting in the right place

ORGOVYX is the only oral androgen deprivation therapy (ADT) and was shown to lower testosterone and PSA levels* in adults with advanced prostate cancer.

*Even though it wasn't the main focus of the clinical trials, PSA (prostate-specific antigen) levels were monitored. Because the clinical trial included many different types of patients, the results of PSA monitoring should be interpreted with caution. No evidence has shown that the speed of PSA decline is related to a clinical benefit.

Image of an ORGOVYX® (relugolix) pill with the text Pill not shown in actual size Image of an ORGOVYX® (relugolix) pill with the text Pill not shown in actual size

*Even though it wasn't the main focus of the clinical trials, PSA (prostate-specific antigen) levels were monitored. Because the clinical trial included many different types of patients, the results of PSA monitoring should be interpreted with caution. No evidence has shown that the speed of PSA decline is related to a clinical benefit.

The lowdown on how ORGOVYX works

Lowering testosterone is one of the main ways to treat advanced prostate cancer. And that's exactly what ORGOVYX does.

Imagine the body makes testosterone the way that water comes out of a faucet

gray faucet icon

Without ORGOVYX, the faucet is turned on and testosterone flows freely.

gold faucet icon

With ORGOVYX, the faucet is almost turned off and the flow of testosterone is slowed, meaning there's less testosterone.

ORGOVYX was studied in a clinical trial

ORGOVYX® (relugolix) clinical trial enrollment ORGOVYX® (relugolix) clinical trial enrollment

ORGOVYX was studied in a clinical trial in more than 900 men with advanced prostate cancer.

Men in the trial were treated for 48 weeks and either took the pill ORGOVYX or received leuprolide acetate injections.

The purpose of the trial was to measure how well ORGOVYX lowered testosterone to the treatment goal of below 50 ng/dL (nanograms per deciliter) from day 29 through week 48.

While it wasn't the main focus of the trial, the trial also monitored how much ORGOVYX was able to lower prostate-specific antigen (PSA) levels.

Because the clinical trial included many different types of patients, the results of PSA monitoring should be interpreted with caution. No evidence has shown that the speed of PSA decline is related to a clinical benefit.

ORGOVYX® (relugolix) clinical trial results - primary endpoint
taking ORGOVYX lowered their testosterone (below 50 ng/dL) by day 29 and kept it low through week 48 
In the clinical trial, 97% of men taking ORGOVYX lowered their testosterone (below 50 ng/dL) by day 29 and kept it low through week 48. For men receiving leuprolide injections, 89% lowered their testosterone by day 29 and kept it low through week 48.

It's important to know that everyone is unique and may see different results. Talk to your doctor about what these clinical trial results may mean for you.
ORGOVYX® (relugolix) clinical trial results - primary endpoint
taking ORGOVYX lowered their testosterone (below 50 ng/dL) by day 29 and kept it low through week 48


In the clinical trial, 97% of men taking ORGOVYX lowered their testosterone (below 50 ng/dL) by day 29 and kept it low through week 48.
For men receiving leuprolide injections, 89% lowered their testosterone by day 29 and kept it low through week 48.

It's important to know that everyone is unique and may see different results. Talk to your doctor about what these clinical trial results may mean for you.

SELECT IMPORTANT SAFETY INFORMATION

Most common side effects of ORGOVYX include:
  • hot flushes
  • increased blood sugar levels
  • increased blood fat (triglyceride) levels
  • muscle and joint pain
  • decreased blood hemoglobin levels
  • increased liver enzymes
  • tiredness
  • constipation
  • diarrhea

ORGOVYX may cause other side effects including weight gain, decreased sex drive, and erectile function problems.

ORGOVYX may cause fertility problems in males, which may affect your ability to father children. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of ORGOVYX. Call your doctor for medical advice about side effects or if you have a side effect that bothers you or does not go away.

You may report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see below for additional safety information.

ORGOVYX was proven to lower testosterone levels fast

After 15 days of treatment, 99% of men taking ORGOVYX lowered their testosterone levels to below 50 ng/dL in the clinical trial and 12% of men receiving leuprolide injections lowered their testosterone levels to below 50 ng/dL.

ORGOVYX® (relugolix) clinical trial results - chartORGOVYX® (relugolix) clinical trial results - chart

ORGOVYX lowered PSA levels, on average, by 92% after 3 months

In the clinical trial, PSA levels were monitored against the pretreatment level (baseline). During the first few months of taking ORGOVYX, men saw their PSA levels were lowered the longer they stayed on treatment, and kept them low throughout the 48-week trial.

In the clinical trial, PSA levels were monitored against the pretreatment level (baseline). During the first few months of taking ORGOVYX, men saw their PSA levels were lowered the longer they stayed on treatment, and kept them low throughout the 48-week trial.

It's important to know that everyone is unique and may see different results. Talk to your doctor about what these clinical trial results may mean for you.

Even though it wasn't the main focus of the clinical trial, PSA (prostate-specific antigen) levels were monitored. Because the clinical trial included many different types of patients, the results of PSA monitoring should be interpreted with caution. No evidence has shown that the speed of PSA decline is related to a clinical benefit.

ORGOVYX® (relugolix) average PSA reduction clinical trial resultsORGOVYX® (relugolix) average PSA reduction clinical trial results

It's important to know that everyone is unique and may see different results. Talk to your doctor about what these clinical trial results may mean for you.

Even though it wasn't the main focus of the clinical trial, PSA (prostate-specific antigen) levels were monitored. Because the clinical trial included many different types of patients, the results of PSA monitoring should be interpreted with caution. No evidence has shown that the speed of PSA decline is related to a clinical benefit.

PSA arrow icon PSA arrow icon
After 3 months, ORGOVYX continued to keep PSA levels low throughout the rest of the 48 weeks of treatment.

Side effects

Before taking ORGOVYX, tell your doctor about all of your medical conditions, including:

  • If you have any heart problems, including a condition called long QT syndrome
  • If you are pregnant or plan to become pregnant. ORGOVYX can harm your unborn baby and cause loss of pregnancy (miscarriage)
  • If you have a partner who is pregnant or may become pregnant. Men who have female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ORGOVYX and for 2 weeks after the last dose of ORGOVYX
  • If you are breastfeeding or plan to breastfeed. It is not known if ORGOVYX passes into your breast milk

What are the possible side effects?

ORGOVYX may cause serious side effects, such as changes in the electrical activity of your heart. This is called QT prolongation. Your doctor may check your salt levels, also known as electrolytes, and the electrical activity of your heart while you are taking ORGOVYX.

Tell your doctor right away if you have any of these signs or symptoms of QT prolongation:

  • Dizziness
  • Fainting
  • Feeling that your heart is pounding or racing (palpitations)
  • Chest pain

ORGOVYX may cause allergic reactions. Stop taking ORGOVYX and tell your healthcare provider or get emergency medical help right away if you get any signs or symptoms of an allergic reaction, including:

  • Swelling of your face, lips, tongue, throat, or trouble swallowing
  • Trouble breathing
  • Hives (raised bumps), rash, or redness all over your body

Common side effects

The most common side effects men experienced while taking ORGOVYX were:

hot flushes icon

Hot flushes, also known as hot flashes

increased blood sugar icon

Increased blood sugar and/or increased blood fat (triglyceride) levels

muscle and joint pain icon

Muscle and joint pain

decreased blood hemoglobin icon

Decreased blood hemoglobin levels

toilet with clock constipation icon

Constipation

increased liver enzymes icon

Increased liver enzymes

roll of toilet paper diarrhea icon

Diarrhea

tiredness icon

Tiredness

ORGOVYX may cause other side effects such as weight gain, decreased sex drive, and erectile function problems.

ORGOVYX may cause fertility problems, which may affect your ability to have children. Talk to your doctor if this is a concern for you.

These are not all the possible side effects of ORGOVYX. Call your doctor for medical advice about side effects or if you have a side effect that bothers you or does not go away.

You may report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Tell your doctor about any side effects that bother you or don't go away. Your doctor may be able to help you find ways to manage them.
In the clinical trial, 3.5% of men taking
ORGOVYX stopped taking it due to side effects.

Know what to ask your doctor?

Icon with two speech bubbles

Get ready for your next visit by using the personalized Doctor Discussion Guide. This guide can help equip you with the most useful questions to ask your doctor.